By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


FORMA Therapeutics, Inc. 

500 Arsenal Street
Suite 100
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-679-1970 Fax: n/a



Cubist Pharmaceuticals, Inc. 

Company News
FORMA Therapeutics, Inc. And Paradigm Announce Molecular Profiling Collaboration For Drug Candidates 8/12/2014 8:27:57 AM
FORMA Therapeutics, Inc. Appoints Duncan Walker, Ph.D., To R&D Leadership Team 6/2/2014 7:42:20 AM
FORMA Therapeutics, Inc. Acquires Covalent Chemistry Platform From Netherlands Cancer Institute (NCI) 5/5/2014 9:48:06 AM
FORMA Therapeutics, Inc. Picks Up Another $225 Million, And A Potential Buyout From Celgene (CELG) 4/1/2014 7:07:07 AM
FORMA Therapeutics, Inc. Announces Advancement Of Collaboration With Boehringer Ingelheim Corporation For Modulating Protein-Protein Interactions In The Treatment Of Cancer 1/9/2014 10:13:21 AM
FORMA Therapeutics, Inc. Appoints Christopher Dinsmore To Vice President, Medicinal And Computational Chemistry 1/7/2014 7:23:29 AM
FORMA Therapeutics, Inc. Achieves First Major Objective to Advance Innovative Protein Homeostasis Drugs With Celgene Corporation (CELG) 10/8/2013 10:10:51 AM
FORMA Therapeutics, Inc. Appoints Chris Kirby to General Counsel 7/25/2013 8:02:39 AM
FORMA Therapeutics, Inc., Cancer Research Technology Deal Part of Broader Research Initiative 7/9/2013 7:11:02 AM
FORMA Therapeutics, Inc. Launches New Collaborative Framework to Transform Basic Research Into Promising Therapies 6/18/2013 9:31:45 AM